Valtoco contains diazepam, a benzodiazepine anticonvulsant and Schedule IV controlled substance, in a ready-to-use nasal spray device. The expanded indication was supported by data from a phase 1/ ...

ARS Pharmaceuticals has announced the availability of neffy (epinephrine nasal spray) 1mg in the US, providing a new option ...

The nasal spray is expected to be available in the United ... government officials or school officials to mandate that this device is included along with epinephrine pens in all of these locations.” ...

Give as single spray intranasally into one nostril. May give additional doses (using a new nasal spray) every 2–3mins in alternate nostrils if unresponsive or relapses into respiratory depression.

The Food and Drug Administration (FDA) has approved Atzumi ™ (dihydroergotamine) nasal powder for the acute treatment of migraine with or without aura in adults.

As for Tosymra nasal spray, Lipton says it’s more effective than generic nasal sumatriptan. “Tosymra is a relatively easy ...

Momcozy launches the SniffEase Baby Nasal Aspirator with hospital-grade suction for safe, effective relief. This easy-to-use device not only provides instant congestion relief but also reduces the ...

“The device is a very intuitive, single-use product.” Nasdepi was developed as a nasal spray because patients who are afraid of needles may delay in administering epinephrine when anaphylaxis ...

"The availability of epinephrine nasal spray may reduce barriers to rapid ... insurance – the price will be $25 for two single-use devices. It is also available at a cash price of $199 for ...

They had given patients oral supplements of vitamin D to reduce nasal inflammation and reverse the loss of the sense of smell the inflammation often causes. "It helped zero of 28 people," she said.

Atzumi combines a proprietary advanced powder and device technology to simplify nasal delivery of dihydroergotamine for acute treatment of migraine.